JFG
Jefferies Financial Group Portfolio holdings
AUM
$6.06B
This Quarter Return
+1.61%
1 Year Return
+9.37%
3 Year Return
+16.02%
5 Year Return
+51.04%
10 Year Return
+258.41%
AUM
$8.96B
AUM Growth
+$8.96B
(+46%)
Cap. Flow
+$2.99B
Cap. Flow
% of AUM
33.3%
Top 10 Holdings %
Top 10 Hldgs %
32.07%
Holding
1,583
New
418
Increased
359
Reduced
278
Closed
274
Top Buys
| 1 |
Amazon
AMZN
|
$374M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$349M |
| 3 |
iShares Russell 2000 ETF
IWM
|
$302M |
| 4 |
Microsoft
MSFT
|
$261M |
| 5 |
SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
$152M |
Top Sells
| 1 |
Apple
AAPL
|
$328M |
| 2 |
NXP Semiconductors
NXPI
|
$111M |
| 3 |
NVIDIA
NVDA
|
$95.2M |
| 4 |
Amgen
AMGN
|
$69.4M |
| 5 |
Shell
SHEL
|
$53.7M |
Sector Composition
| 1 | Healthcare | 15.8% |
| 2 | Technology | 15.29% |
| 3 | Consumer Discretionary | 10.36% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Celldex Therapeutics
CLDX
$1.57B
| $60.4M | 0.36% |
2,390,398
+2,369,398
| +11,283% | +$59.9M |
|
27
CCC Intelligent Solutions
CCCS
$6.34B
| $58.1M | 0.35% |
+4,951,387
| New | +$58.1M |
|
28
Protagonist Therapeutics
PTGX
$3.62B
| $57.5M | 0.34% |
1,489,495
-325,201
| -18% | -$12.6M |
|
29
SPDR S&P Biotech ETF
XBI
$5.29B
| $55M | 0.33% |
610,733
+541,290
| +779% | +$48.7M |
|
30
Berkshire Hathaway Class B
BRK.B
$1.08T
| $50.4M | 0.3% |
111,223
+110,231
| +11,112% | +$50M |
|
|
31
Alphabet (Google) Class C
GOOG
$2.79T
| $50.2M | 0.3% |
263,610
+246,470
| +1,438% | +$46.9M |
|
32
Agios Pharmaceuticals
AGIO
$2.36B
| $49.3M | 0.3% |
+1,500,000
| New | +$49.3M |
|
33
Sprinklr
CXM
$2B
| $49.1M | 0.29% |
5,807,400
+2,851,106
| +96% | +$24.1M |
|
34
Caesars Entertainment
CZR
$5.18B
| $46.4M | 0.28% |
1,388,067
+1,351,286
| +3,674% | +$45.2M |
|
|
TGI
35
DELISTED
Triumph Group
TGI
| $45.5M | 0.27% |
2,437,013
+538
| +0% | +$10K |
|
36
Antero Resources
AR
$9.82B
| $44.3M | 0.26% |
1,262,605
-268,648
| -18% | -$9.42M |
|
37
Progress Software
PRGS
$1.93B
| $44.1M | 0.26% |
676,835
+662,881
| +4,750% | +$43.2M |
|
38
Crown Castle
CCI
$42.3B
| $43.6M | 0.26% |
480,030
+476,556
| +13,718% | +$43.3M |
|
39
US Bancorp
USB
$75.5B
| $43.2M | 0.26% |
903,622
+893,286
| +8,642% | +$42.7M |
|
40
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.4B
| $42.8M | 0.26% |
480,179
+390,000
| +432% | +$34.7M |
|
41
Dyne Therapeutics
DYN
$1.92B
| $42.4M | 0.25% |
+1,800,000
| New | +$42.4M |
|
42
Cisco
CSCO
$268B
| $40.8M | 0.24% |
689,603
+603,286
| +699% | +$35.7M |
|
43
Apogee Therapeutics
APGE
$2.27B
| $40.2M | 0.24% |
887,497
+518,300
| +140% | +$23.5M |
|
44
Schlumberger
SLB
$52.2B
| $39.6M | 0.24% |
1,033,530
+716,435
| +226% | +$27.5M |
|
|
45
Amgen
AMGN
$153B
| $36.1M | 0.22% |
138,481
-266,142
| -66% | -$69.4M |
|
46
Pfizer
PFE
$141B
| $35.3M | 0.21% |
1,330,905
+813,374
| +157% | +$21.6M |
|
47
Southwest Airlines
LUV
$17B
| $34.1M | 0.2% |
1,013,657
+979,388
| +2,858% | +$32.9M |
|
48
Tesla
TSLA
$1.08T
| $33.7M | 0.2% |
83,529
+79,108
| +1,789% | +$31.9M |
|
|
LGF.A
49
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $31.8M | 0.19% |
3,726,250
+1,250
| +0% | +$10.7K |
|
50
Broadcom
AVGO
$1.42T
| $30.6M | 0.18% |
132,015
+122,379
| +1,270% | +$28.4M |
|